Ethan Rubinstein
- Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria 27
-
- Antibiotic Use and Resistance 10
- Clinical Biochemistry top 0.2%
- Bacterial Identification and Susceptibility Testing 19
- Infectious Diseases top 0.5%
- Antimicrobial Resistance in Staphylococcus 36
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 39
-
- Pneumonia and Respiratory Infections 29
- Infective Endocarditis Diagnosis and Management 16
-
- Streptococcal Infections and Treatments 15
- Co-authors
- James A. KarlowskyGeorge G. ZhanelDaryl J. HobanYoav KeynanPhilippe Lagacé‐WiensAlfred S. GinSheryl ZelenitskyFrank Schweizer
- Journals
- Drugs (10 papers)Journal of Antimicrobial Chemotherapy (8 papers)Antimicrobial Agents and Chemotherapy (8 papers)
- Partner nations
- CanadaIsraelUnited States
In The Last Decade
Ethan Rubinstein
138 papers receiving 6.5k citations
Peers
Comparison fields: 5 of 151
- Molecular Medicine 1.8k
- Applied Microbiology and Biotechnology 616
- Clinical Biochemistry 877
- Infectious Diseases 2.4k
- Pharmacology 1.8k
Countries citing papers authored by Ethan Rubinstein
This map shows the geographic impact of Ethan Rubinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ethan Rubinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ethan Rubinstein more than expected).
Fields of papers citing papers by Ethan Rubinstein
This network shows the impact of papers produced by Ethan Rubinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ethan Rubinstein. The network helps show where Ethan Rubinstein may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ethan Rubinstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 3 | |
| 2 | 2015 | 138 | |
| 3 | 2014 | 60 | |
| 4 | 2014 | 32 | |
| 5 | セフタジジム-アビバクタム: 新規セファロスポリン/β-ラクタマーゼ阻害剤の併用 | 2013 | 1 |
| 6 | 2013 | 8 | |
| 7 | 2011 | 55 | |
| 8 | 2010 | 14 | |
| 9 | 2009 | 170 | |
| 10 | 2009 | 118 | |
| 11 | Telavancin for the Treatment of Hospital-Acquired Pneumonia in Severely Ill and Older Patients: The ATTAIN Studies | 2008 | 2 |
| 12 | Telavancin for Treatment of Hospital-Acquired Pneumonia (HAP) Caused by MRSA and MSSA: The ATTAIN Studies | 2008 | 5 |
| 13 | 2008 | 31 | |
| 14 | 2004 | 203 | |
| 15 | 2002 | 16 | |
| 16 | 1999 | 2 | |
| 17 | 1998 | 10 | |
| 18 | 1998 | 20 | |
| 19 | 1997 | 11 | |
| 20 | 1974 | 21 |
About Ethan Rubinstein
Ethan Rubinstein is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 140 papers that have together received 6.8k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (39 papers), Antimicrobial Resistance in Staphylococcus (36 papers), Pneumonia and Respiratory Infections (29 papers), Antibiotic Resistance in Bacteria (27 papers), Bacterial Identification and Susceptibility Testing (19 papers), Infective Endocarditis Diagnosis and Management (16 papers), Streptococcal Infections and Treatments (15 papers) and Antibiotic Use and Resistance (10 papers). The work is most often cited by research in Molecular Medicine (1.8k citations), Applied Microbiology and Biotechnology (616 citations) and Clinical Biochemistry (877 citations). Ethan Rubinstein has collaborated with scholars based in Canada, Israel and United States. Frequent co-authors include James A. Karlowsky, George G. Zhanel, Daryl J. Hoban, Yoav Keynan, Philippe Lagacé‐Wiens, Alfred S. Gin, Sheryl Zelenitsky, Frank Schweizer, Heather J. Adam and Marin H. Kollef. Their work appears in journals such as Drugs, Journal of Antimicrobial Chemotherapy, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.